Related Experiment Video

Updated: Feb 24, 2026

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma
06:21

Ultrasound-Guided Orthotopic Implantation of Murine Pancreatic Ductal Adenocarcinoma

Published on: November 19, 2019

12.3K

The Yolk Sac Feeds Pancreatic Tumors

Jeffrey W Pollard1

  • 1MRC and University of Edinburgh Centre for Reproductive Health, Queen's Medical Research Institute, University of Edinburgh, Edinburgh, UK; Department of Developmental and Molecular Biology; Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.

Immunity
|August 17, 2017
PubMed

Insights

Tumor-associated macrophages in pancreatic cancer originate from the yolk sac and bone marrow. Only yolk sac-derived macrophages drive pancreatic ductal adenocarcinoma progression and growth.

Area of Science:

  • Immunology
  • Cancer Biology
  • Oncology

Background:

  • Tumor-associated macrophages (TAMs) are key regulators of the tumor microenvironment.
  • The origin and specific roles of different TAM subsets in pancreatic ductal adenocarcinoma (PDAC) remain incompletely understood.

Purpose of the Study:

  • To investigate the developmental origins of TAMs in a mouse model of PDAC.
  • To determine the functional contribution of distinct TAM populations to PDAC progression.

Main Methods:

  • Utilized a mouse model of pancreatic ductal adenocarcinoma (PDAC).
  • Employed differential ablation strategies to selectively eliminate yolk sac (YS)-derived and bone marrow (BM)-derived macrophages.
  • Assessed the impact of macrophage ablation on tumor growth and progression.

Main Results:

  • Identified that TAMs in PDAC originate from both embryonic yolk sac (YS) and adult bone marrow (BM).
  • Demonstrated that selective ablation of YS-derived macrophages significantly impaired PDAC progression and growth.
  • Showed that ablation of BM-derived macrophages had a minimal impact on tumor progression.

Conclusions:

  • YS-derived macrophages are critical drivers of PDAC progression.
  • Targeting YS-derived TAMs represents a potential therapeutic strategy for pancreatic cancer.
  • Understanding TAM ontogeny is crucial for developing effective cancer immunotherapies.

More Related Videos

Fluorescent Orthotopic Mouse Model of Pancreatic Cancer06:48

Fluorescent Orthotopic Mouse Model of Pancreatic Cancer

Published on: September 20, 2016

17.8K
An Orthotopic Resectional Mouse Model of Pancreatic Cancer07:17

An Orthotopic Resectional Mouse Model of Pancreatic Cancer

Published on: September 24, 2020

12.7K

Related Concept Videos

Pancreas01:19

Pancreas

The pancreas, an essential organ in the human body, is a pinkish-gray elongated structure located posterior to the stomach. It extends laterally from the duodenum towards the spleen and is firmly bound to the posterior wall of the abdominal cavity. The organ's surface has a lumpy, lobular texture that gives it a unique appearance.
The broad head of the pancreas lies within the loop formed by the duodenum, while its slender body reaches towards the spleen. The tail of the pancreas is short...
2.6K
Pancreatic Juice and Secretion01:26

Pancreatic Juice and Secretion

Pancreatic juice is a clear fluid produced by the pancreas, containing water, salts, sodium bicarbonate, and enzymes vital for digestion in the small intestine. It helps break down large molecules, facilitating nutrient absorption.
When acidic chyme from the stomach enters the duodenum, it triggers the release of secretin, a hormone that prompts pancreatic juice secretion. After a fatty meal, cholecystokinin, another hormone, stimulates gallbladder contraction and enhances enzyme-rich...
3.2K